Virus Specific T-Cell Terminated Phase 1 Trials for Viral Infections / Coronavirus Disease 2019 (COVID‑19) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04401410 | Anti-SARS Cov-2 T Cell Infusions for COVID 19 |